Viral Vector Production Market: Supporting Gene Therapy and Vaccine Development up to 2033
The Viral Vector Production market includes the development and manufacturing of viral vectors used as delivery mechanisms for gene therapy, vaccine production, and other advanced therapeutics. Viral vectors, such as adenovirus, lentivirus, and adeno-associated virus (AAV), are engineered to carry genetic material into cells, facilitating the treatment of genetic disorders, cancers, and infectious diseases. This market serves biotechnology, pharmaceutical, and research institutions that require viral vectors for clinical trials, therapeutic applications, and vaccine development.